UnitedHealth Group Incorporated (NYSE:UNH) is Ocean Capital Management LLC’s 8th Largest Position

Ocean Capital Management LLC increased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 5.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 13,623 shares of the healthcare conglomerate’s stock after acquiring an additional 682 shares during the period. UnitedHealth Group comprises approximately 2.9% of Ocean Capital Management LLC’s portfolio, making the stock its 8th biggest holding. Ocean Capital Management LLC’s holdings in UnitedHealth Group were worth $7,172,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. Keebeck Wealth Management LLC grew its holdings in UnitedHealth Group by 11.6% during the second quarter. Keebeck Wealth Management LLC now owns 10,788 shares of the healthcare conglomerate’s stock valued at $5,185,000 after purchasing an additional 1,122 shares during the period. Ascension Capital Advisors Inc. bought a new position in UnitedHealth Group during the third quarter valued at $216,000. Physician Wealth Advisors Inc. bought a new position in shares of UnitedHealth Group in the third quarter worth $207,000. Bartlett & Co. LLC boosted its holdings in shares of UnitedHealth Group by 5.7% in the third quarter. Bartlett & Co. LLC now owns 164,353 shares of the healthcare conglomerate’s stock worth $82,865,000 after acquiring an additional 8,873 shares during the period. Finally, Great Valley Advisor Group Inc. boosted its holdings in shares of UnitedHealth Group by 5.8% in the third quarter. Great Valley Advisor Group Inc. now owns 34,297 shares of the healthcare conglomerate’s stock worth $17,292,000 after acquiring an additional 1,884 shares during the period. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Stock Up 0.3 %

NYSE:UNH traded up $1.60 during mid-day trading on Thursday, hitting $494.70. 3,805,551 shares of the company’s stock were exchanged, compared to its average volume of 4,097,774. UnitedHealth Group Incorporated has a one year low of $445.68 and a one year high of $554.70. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.79 and a quick ratio of 0.79. The business has a fifty day moving average price of $503.10 and a 200 day moving average price of $518.61. The company has a market cap of $456.08 billion, a PE ratio of 20.70, a P/E/G ratio of 1.34 and a beta of 0.54.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.98 by $0.18. The firm had revenue of $94.43 billion for the quarter, compared to the consensus estimate of $92.13 billion. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.39%. The business’s revenue was up 14.1% on a year-over-year basis. During the same quarter in the prior year, the firm posted $5.34 earnings per share. Equities analysts predict that UnitedHealth Group Incorporated will post 27.82 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were issued a dividend of $1.88 per share. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 annualized dividend and a dividend yield of 1.52%. UnitedHealth Group’s payout ratio is 31.54%.

Insider Activity

In other news, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

A number of equities analysts have recently commented on the company. Truist Financial reaffirmed a “buy” rating and issued a $610.00 price target on shares of UnitedHealth Group in a report on Thursday, November 30th. Stephens reiterated an “overweight” rating and issued a $605.00 price objective on shares of UnitedHealth Group in a research report on Thursday, February 8th. Bank of America restated a “buy” rating and set a $675.00 price target on shares of UnitedHealth Group in a research report on Thursday, March 7th. Oppenheimer restated an “outperform” rating and set a $610.00 price target on shares of UnitedHealth Group in a research report on Wednesday, January 17th. Finally, Royal Bank of Canada restated an “outperform” rating and set a $596.00 price target on shares of UnitedHealth Group in a research report on Thursday, February 29th. One investment analyst has rated the stock with a sell rating, two have given a hold rating, fifteen have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $579.33.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.